Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in France next month following the successful resumption of product shipments.

Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in ...

Allurion Technologies Inc (NYSE:ALUR) achieved a first-quarter revenue of $5.6 million with a significant decrease in operating expenses by 45% compared to the previous year. The company reported ...

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform offers the Allurion Program, a swallowable and procedure-less ...

NATICK, Mass., May 29, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that Dr. Shantanu Gaur, Founder and ...

Allurion Technologies Inc (NYSE:ALUR) achieved a first-quarter revenue of $5.6 million with a significant decrease in operating expenses by 45% compared to the previous year. The company reported an ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...